Dérivés de Quinazoline et de Quinoléine
Les quinazolines et les quinoléines sont des composés hétérocycliques azotés à structure aromatique qui jouent un rôle clé dans la synthèse de médicaments à activité anticancéreuse, antimicrobienne et anti-inflammatoire. Leurs dérivés présentent des modifications structurelles qui optimisent leur biodisponibilité et leur sélectivité, permettant ainsi le développement de nouveaux principes actifs pour diverses applications thérapeutiques. Ces composés sont utilisés dans la fabrication d’API destinés au traitement du cancer, des infections, des maladies neurodégénératives et cardiovasculaires. De plus, les dérivés de quinazoline et de quinoléine sont essentiels dans la recherche d’inhibiteurs enzymatiques et dans la conception de molécules bioactives innovantes.
Chez CymitQuimica, nous proposons des dérivés de quinazoline et de quinoléine de haute pureté pour des applications en synthèse chimique, développement pharmaceutique et biotechnologie.
65624 produits trouvés pour "Dérivés de Quinazoline et de Quinoléine"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
Sodium Starch Glycolate Type A
CAS :Modified starches, nesoiFormule :(C2H4O3)x·(Na)xCouleur et forme :White Off-White PowderMasse moléculaire :515.6862Atazanavir Ethyl Analog (methyl ((6S,11S,12S,15S)-12-benzyl-6-(tert-butyl)-11-hydroxy-16,16-dimethyl-4,7,14-trioxo-9-(4-(pyridin-2-yl)benzyl)-3-oxa-5,8,9,13-tetraazaheptadecan-15-yl)carbamate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C39H54N6O7Couleur et forme :Off-White SolidMasse moléculaire :718.4054Aminoethyl Fluvoxamine Dihydrochloride ((E)-5-Methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one O-{2-[(2-aminoethyl)amino]ethyl}oxime dihydrochloride)
CAS :Aromatic organic derivatives of hydrazine or of hydroxylamineFormule :C17H26F3N3O2·2HClCouleur et forme :White PowderMasse moléculaire :433.15107Clioquinol Related Compound A (5-Chloroquinolin-8-ol)
CAS :Compounds containing a quinoline or isoquinoline ring-system, whether or not hydrogenated, not further fused, excluding drugs and pesticidesFormule :C9H6ClNOCouleur et forme :Off-White PowderMasse moléculaire :179.01379Nadolol Related Compound F (1-(tert-Butylamino)-3-(naphthalen-1-yloxy)propan-2-ol)
CAS :Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFormule :C17H23NO2Couleur et forme :Off-White SolidMasse moléculaire :273.17288Norepinephrine Bitartrate
CAS :Catecholamine hormones (excluding epinephrine), their derivatives and structural analoguesFormule :C8H11NO3·C4H6O6·H2OCouleur et forme :White Light Grey Crystalline PowderMasse moléculaire :337.28Naproxen Related Compound A (6-methoxy-2-naphthoic acid)
CAS :Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFormule :C12H10O3Couleur et forme :White Off-White PowderMasse moléculaire :202.21Desethylamiodarone (2-Butyl-3-benzofuranyl-4-[2-(ethylamino)ethoxy]-3,5-diiodophenyl Ketone Hydrochloride)
CAS :Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C23H25I2NO3·HClCouleur et forme :White Off-White SolidMasse moléculaire :652.96907Nadolol
CAS :Aromatic drugs of amino-alcohols, other than those contFormule :C17H27NO4Couleur et forme :White PowderMasse moléculaire :309.4 g/molDarunavir Ethanolate
CAS :Sulfonamides used as drugsFormule :C27H37N3O7S·C2H6OCouleur et forme :White Beige PowderMasse moléculaire :593.27709Oxcarbazepine Related Compound C (Acridin-9(10H)-one)
CAS :Aromatic or modified aromatic heterocyclic compounds wiFormule :C13H9NOCouleur et forme :Yellow Green SolidMasse moléculaire :195.06841Phenylpropoxy Salmeterol (4-(1-hydroxy-2-((6-(3-phenylpropoxy)hexyl)amino)ethyl)-2-(hydroxymethyl)phenol; 4-{1-Hydroxy-2-[6-(3-phenylpropoxy)hexylamino]ethyl}-2-(hydroxymethyl)phenol)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C24H35NO4Couleur et forme :White Off-White SolidMasse moléculaire :401.55Paroxetine Related Compound F ((3S,4R)-3-[(Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-methylpiperidine)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C20H22FNO3Couleur et forme :Light Tan PowderMasse moléculaire :343.15837Clioquinol Related Compound B (5,7-Dichloroquinolin-8-ol)
CAS :Drugs containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fusedFormule :C9H5Cl2NOCouleur et forme :White Off-White PowderMasse moléculaire :212.97482Apremilast R-Enantiomer
CAS :Other aromatic organo-sulfur compounds (excluding pesticides)Formule :C22H24N2O7SCouleur et forme :White Off-White PowderMasse moléculaire :460.13042Ofloxacin Related Compound A (9-Fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C17H18FN3O4Couleur et forme :Light Yellow PowderMasse moléculaire :347.34Dofetilide Related Compound B (N-Methyl-N-[4-(methylsulfonamido)phenethyl]-2-[4-(methylsulfonamido)phenoxy]ethan-1-amine oxide)
CAS :Sulfonamides, nesoiFormule :C19H27N3O6S2Couleur et forme :Off-White PowderMasse moléculaire :457.13413Ofloxacin
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C18H20FN3O4Couleur et forme :Off-White Pale Yellow PowderMasse moléculaire :361.14378Naproxen Sodium
CAS :Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFormule :C14H13NaO3Couleur et forme :White Cream PowderMasse moléculaire :252.07624Paroxetine Related Compound B ((3S,4R)-3-[(Benzodioxol-5-yloxy)methyl]-4-phenylpiperidine hydrochloride)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C19H21NO3·HClCouleur et forme :White PowderMasse moléculaire :347.84Paliperidone Resolution Mixture
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCouleur et forme :White PowderRivaroxaban N-acyl glycolic acid ((S)-2-(2-(5-chloro-N-(4-(5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)thiophene-2-carboxamido)ethoxy)acetic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C24H21Cl2N3O7S2Couleur et forme :Off-White SolidMasse moléculaire :597.0198N-Nitroso Metoprolol Solution (1 mL ) (N-(2-hydroxy-3-(4-(2-methoxyethyl)phenoxy)propyl)-N-isopropylnitrous amide)
CAS :Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiFormule :C15H24N2O4Couleur et forme :Colorless LiquidMasse moléculaire :296.17361Metoprolol Fumarate
CAS :Aromatic drugs of amino-alcohols, other than those contFormule :C34H54N2O10Couleur et forme :White Off-White Crystalline PowderMasse moléculaire :650.8Methoxyethyl Phenol
CAS :Ether-phenols, ether-alcohol-phenols and their halogenated, sulfonated, nitrated or nitrosated derivativesFormule :C9H12O2Couleur et forme :White PowderMasse moléculaire :152.08373Rivaroxaban Ethylamino Analog (1-amino-3-((4-(3-oxomorpholino)phenyl)amino)propan-2-yl 5-chlorothiophene-2-carboxylate, hydrochloride)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C18H20ClN3O4S·2HClCouleur et forme :White Off-White SolidMasse moléculaire :482.81Rivaroxaban Glycolic Acid Analog ((S)-2-(2-((4-(5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)amino)ethoxy)acetic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C19H20ClN3O6SCouleur et forme :Pale Yellow SolidMasse moléculaire :453.89Leflunomide Tolyl Analog (5-Methyl-N-(4-methylphenyl)-4-isoxazolecarboxamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C12H12N2O2Couleur et forme :White PowderMasse moléculaire :216.08988Diphthalimido Morpholinone Analog (2,2'-((2R,2'R)-((4-(3-oxomorpholino)phenyl)azanediyl)bis(2-hydroxypropane-3,1-diyl))bis(isoindoline-1,3-dione))
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C32H30N4O8Couleur et forme :Pale Yellow SolidMasse moléculaire :598.20636Ambrisentan Related Compound D (2-[(2,2-Diphenylvinyl)oxy]-4,6-dimethylpyrimidine)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C20H18N2OCouleur et forme :Off-White Fine PowderMasse moléculaire :302.14191Leflunomide Related Compound A (4-(trifluoromethyl)aniline)
CAS :Toluidines (aminotoluenes) and their derivatives, salts thereofFormule :C7H6F3NCouleur et forme :White Light Yellow LiquidMasse moléculaire :161.04523Aripiprazole
CAS :Lactams, nesoiFormule :C23H27Cl2N3O2Couleur et forme :White Pale Yellow PowderMasse moléculaire :447.14803Aripiprazole Spiro Analog (8-(2,3-dichlorophenyl)-5,8-diazaspiro[4.5]decan-5-ium, bromide)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C14H19Cl2N2·BrCouleur et forme :White Off-White SolidMasse moléculaire :366.124'-Hydroxycelecoxib (4-(5-(4-(hydroxymethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide)
CAS :Sulfonamides, nesoiFormule :C17H14F3N3O3SCouleur et forme :White Off-White SolidMasse moléculaire :397.37Celecoxib Related Compound B (4-[3-(4-methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide)
CAS :Sulfonamides, nesoiFormule :C17H14F3N3O2SCouleur et forme :White SolidMasse moléculaire :381.07588Saxagliptin Related Compound B (Saxagliptin amide analog (1S,3S,5S)-2-{(S)-2-Amino-2-[(1r,3R,5R,7S)-3-hydroxyadamantan-1-yl]acetyl}-2-azabicyclo[3.1.0]hexane-3-carboxamide)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, excluding aromatic or modified aromaticFormule :C18H27N3O3Couleur et forme :White Fine PowderMasse moléculaire :333.20524Fluvoxamine Maleate
CAS :Aromatic organic derivatives of hydrazine or of hydroxylamineFormule :C15H21F3N2O2·C4H4O4Couleur et forme :White Off-White Crystalline PowderMasse moléculaire :318.15551Dabigatran Etexilate Mesylate
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C34H41N7O5·CH4O3SCouleur et forme :White Off-White Yellow PowderMasse moléculaire :723.305032,4-Disulfamyl-5-Trifluoromethylaniline
CAS :Sulfonamides, nesoiFormule :C7H8F3N3O4S2Couleur et forme :PowderMasse moléculaire :318.99083Omeprazole Related Compound F and G Mixture
Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormule :C16H13N3O2SCouleur et forme :Dark Brown PowderMasse moléculaire :311.07285Omeprazole Related Compound C (5-Methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylthio]-1H-benzimidazole)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C17H19N3O2SCouleur et forme :White Off-White PowderMasse moléculaire :329.1198Carvedilol System Suitability Mixture (carvedilol spiked with carvedilol related compound F)
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCouleur et forme :White PowderOndansetron Hydrochloride
CAS :Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormule :C18H19N3O·HCl·2H2OCouleur et forme :White Off-White PowderMasse moléculaire :293.15281Celecoxib
CAS :Sulfonamides used as drugsFormule :C17H14F3N3O2SCouleur et forme :PowderMasse moléculaire :381.07588Labetalol Related Compound F (2-Hydroxy-5-[(4-phenylbutan-2-yl)glycyl]benzamide hydrochloride)
CAS :<p>Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereof</p>Formule :C19H22N2O3·HClCouleur et forme :White Off-White PowderMasse moléculaire :362.13972Amiodarone Hydrochloride
CAS :Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C25H29I2NO3·HClCouleur et forme :White PowderMasse moléculaire :681.78 g/molDuloxetine Related Compound A ((R)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine hydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C18H19NOS·HClCouleur et forme :Off-White SolidMasse moléculaire :297.11874Metoprolol Related Compound C (4-[2-Hydroxy-3-(isopropylamino)propoxy]benzaldehyde hydrochloride)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C13H19NO3·HClCouleur et forme :White PowderMasse moléculaire :237.13649Levetiracetam Related Compound A ((S)-N-(1-amino-1-oxobutan-2-yl)-4-chlorobutanamide)
CAS :Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormule :C8H15ClN2O2Couleur et forme :White Off-White CrystalsMasse moléculaire :206.08Ondansetron Related Compound A (3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one hydrochloride)
CAS :Drugs with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C16H20N2O·HClCouleur et forme :White SolidMasse moléculaire :256.15756
![Celecoxib Related Compound B (4-[3-(4-methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesul…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1098526.webp&w=3840&q=75)
![Ondansetron Related Compound A (3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1478593.webp&w=3840&q=75)